Trials / Unknown
UnknownNCT01566578
A Physiological Study on Downregulation of EGF-receptors in the Skin by Topical Exposition With EGF
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- Ennar Pharmaceuticals AF · Industry
- Sex
- Male
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Investigation of EGF-Receptor Downregulation by topical EGF (dermal cream) exposition.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Human recombinant epidermal growth factor | topical |
| OTHER | Placebo cream | Dermal cream without EGF |
Timeline
- Start date
- 2012-04-01
- Primary completion
- 2012-11-01
- Completion
- 2012-11-01
- First posted
- 2012-03-29
- Last updated
- 2012-08-03
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT01566578. Inclusion in this directory is not an endorsement.